Inventor · disambiguated record
Elizabeth-Edna Mary Menendez
Also filed as: MENENDEZ ELIZABETH-EDNA MARY
12 granted patents·2 pending applications·198 citations·filing 2013–2023
92Inventor score
Files withCYTOMX THERAPEUTICS INC14
Top patents by PatentIndex Score
14 records- 0197US10709799B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·10 cites·31 claims
- 0297US9889211B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Feb 13, 2018·29 cites·52 claims
- 0397US9127053B2Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2013·Granted Sep 8, 2015·39 cites·33 claims
- 0497US9120853B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2013·Granted Sep 1, 2015·52 cites·43 claims
- 0596US9545442B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted Jan 17, 2017·19 cites·57 claims
- 0695US10301380B2Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·17 cites·29 claims
- 0794US11867695B2Compositions and methods for detecting protease activity in biological systemsCYTOMX THERAPEUTICS INC·Filed 2021·Granted Jan 9, 2024·2 cites·26 claims
- 0893US11890354B2Activatable antibodies that bind epidermal growth factor receptor and methods thereofCYTOMX THERAPEUTICS INC·Filed 2020·Granted Feb 6, 2024·2 cites·16 claims
- 0993US9688748B2Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted Jun 27, 2017·11 cites·39 claims
- 1091US11035859B2Compositions and methods for detecting protease activity in biological systemsCYTOMX THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·3 cites·37 claims
- 1190US12502439B2Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Granted Dec 23, 2025·0 cites·20 claims
- 1290US10261083B2Compositions and methods for detecting protease activity in biological systemsCYTOMX THERAPEUTICS INC·Filed 2014·Granted Apr 16, 2019·14 cites·20 claims
- 1385US2024337658A1Compositions and methods for detecting protease activity in biological systemsCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1463US2019367589A1Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elizabeth-Edna Mary Menendez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →